DI ANTALVIC

Di Antalvic Adverse Events Reported to the FDA Over Time

How are Di Antalvic adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Di Antalvic, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Di Antalvic is flagged as the suspect drug causing the adverse event.

Most Common Di Antalvic Adverse Events Reported to the FDA

What are the most common Di Antalvic adverse events reported to the FDA?

Cholestasis	30 (2.29%)
Aspartate Aminotransferase Increase...	27 (2.06%)
Cytolytic Hepatitis	27 (2.06%)
Fall	25 (1.91%)
Alanine Aminotransferase Increased	23 (1.76%)
Renal Failure	23 (1.76%)
Renal Failure Acute	22 (1.68%)
Blood Alkaline Phosphatase Increase...	18 (1.38%)
Gamma-glutamyltransferase Increased	18 (1.38%)
Vomiting	16 (1.22%)
Confusional State	15 (1.15%)
	Show More
Jaundice	14 (1.07%)
Somnolence	14 (1.07%)
Blood Creatinine Increased	13 (.99%)
Asthenia	12 (.92%)
Hypotension	12 (.92%)
Pyrexia	12 (.92%)
Agranulocytosis	11 (.84%)
Dehydration	11 (.84%)
Drug Interaction	10 (.76%)
Dyspnoea	10 (.76%)
Thrombocytopenia	10 (.76%)
General Physical Health Deteriorati...	9 (.69%)
Headache	9 (.69%)
Pruritus	9 (.69%)
Toxic Skin Eruption	9 (.69%)
Disorientation	8 (.61%)
International Normalised Ratio Incr...	8 (.61%)
Nausea	8 (.61%)
Anaemia	7 (.54%)
Cerebrovascular Accident	7 (.54%)
Cholelithiasis	7 (.54%)
Eczema	7 (.54%)
Hyponatraemia	7 (.54%)
Lung Disorder	7 (.54%)
Pancytopenia	7 (.54%)
Rash	7 (.54%)
Acute Generalised Exanthematous Pus...	6 (.46%)
Condition Aggravated	6 (.46%)
Constipation	6 (.46%)
Eosinophilia	6 (.46%)
Erythema Multiforme	6 (.46%)
Haemoglobin Decreased	6 (.46%)
Head Injury	6 (.46%)
Hepatic Encephalopathy	6 (.46%)
Hepatitis	6 (.46%)
Hepatomegaly	6 (.46%)
Hyperkalaemia	6 (.46%)
Hyperthermia	6 (.46%)
Memory Impairment	6 (.46%)
Neutropenia	6 (.46%)
Overdose	6 (.46%)
Rash Maculo-papular	6 (.46%)
Abdominal Pain	5 (.38%)
Aphasia	5 (.38%)
Blood Bilirubin Increased	5 (.38%)
Dermatitis Exfoliative	5 (.38%)
Diarrhoea	5 (.38%)
Drug Abuser	5 (.38%)
Drug Rash With Eosinophilia And Sys...	5 (.38%)
Febrile Neutropenia	5 (.38%)
Hepatic Failure	5 (.38%)
Hepatic Steatosis	5 (.38%)
Hepatitis Cholestatic	5 (.38%)
Hepatocellular Injury	5 (.38%)
Inflammation	5 (.38%)
Malaise	5 (.38%)
Metabolic Acidosis	5 (.38%)
Oedema Peripheral	5 (.38%)
Pulmonary Arterial Hypertension	5 (.38%)
Skin Lesion	5 (.38%)
Suicide Attempt	5 (.38%)
Urinary Retention	5 (.38%)
Abortion Induced	4 (.31%)
Asterixis	4 (.31%)
Bundle Branch Block Left	4 (.31%)
C-reactive Protein Increased	4 (.31%)
Drug Exposure During Pregnancy	4 (.31%)
Eosinophil Count Increased	4 (.31%)
Erythema	4 (.31%)
Intentional Overdose	4 (.31%)
Leukocytosis	4 (.31%)
Leukopenia	4 (.31%)
Loss Of Consciousness	4 (.31%)
Lymphadenopathy	4 (.31%)
Melaena	4 (.31%)
Mitral Valve Incompetence	4 (.31%)
Pancreatitis Acute	4 (.31%)
Pulmonary Fibrosis	4 (.31%)
Rash Erythematous	4 (.31%)
Respiratory Distress	4 (.31%)
Sepsis	4 (.31%)
Septic Shock	4 (.31%)
Skin Exfoliation	4 (.31%)
Abdominal Pain Upper	3 (.23%)
Amnesia	3 (.23%)
Anticonvulsant Drug Level Above The...	3 (.23%)
Ascites	3 (.23%)
Autoimmune Hepatitis	3 (.23%)
Balance Disorder	3 (.23%)
Blood Amylase Increased	3 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Di Antalvic, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Di Antalvic is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Di Antalvic

What are the most common Di Antalvic adverse events reported to the FDA?

Hepatic And Hepatobiliary	121 (9.25%)
Epidermal And Dermal Conditions	94 (7.19%)
Hepatobiliary	81 (6.19%)
Neurological	57 (4.36%)
Renal Disorders	47 (3.59%)
Gastrointestinal Signs	41 (3.13%)
Injuries	39 (2.98%)
White Blood Cell	38 (2.91%)
Respiratory	37 (2.83%)
Hematology Investigations	28 (2.14%)
Deliria	26 (1.99%)
	Show More
Electrolyte And Fluid Balance Condi...	26 (1.99%)
Enzyme	21 (1.61%)
Anemias Nonhemolytic And Marrow Dep...	20 (1.53%)
Body Temperature Conditions	20 (1.53%)
Medication Errors	20 (1.53%)
Infections - Pathogen Unspecified	19 (1.45%)
Renal And Urinary Tract Investigati...	18 (1.38%)
Decreased And Nonspecific Blood Pre...	17 (1.3%)
Bacterial Infectious	15 (1.15%)
Cardiac Arrhythmias	14 (1.07%)
Gastrointestinal Motility And Defec...	13 (.99%)
Mental Impairment	13 (.99%)
Platelet	13 (.99%)
Therapeutic And Nontherapeutic Effe...	13 (.99%)
Urinary Tract Signs	13 (.99%)
Lower Respiratory Tract Disorders	12 (.92%)
Central Nervous System Vascular	11 (.84%)
Headaches	9 (.69%)
Movement Disorders	9 (.69%)
Chemical Injury And Poisoning	8 (.61%)
Encephalopathies	8 (.61%)
Gastrointestinal	8 (.61%)
Pulmonary Vascular	8 (.61%)
Suicidal And Self-injurious Behavio...	8 (.61%)
Toxicology And Therapeutic Drug Mon...	8 (.61%)
Cardiac And Vascular Investigations	7 (.54%)
Cardiac Valve	7 (.54%)
Gallbladder	7 (.54%)
Lifestyle Issues	7 (.54%)
Oral Soft Tissue Conditions	7 (.54%)
Skin Vascular Abnormalities	7 (.54%)
Acid-base	6 (.46%)
Exocrine Pancreas Conditions	6 (.46%)
Gastrointestinal Ulceration And Per...	6 (.46%)
Water, Electrolyte And Mineral	6 (.46%)
Bone And Joint Injuries	5 (.38%)
Disturbances In Thinking	5 (.38%)
Fatal Outcomes	5 (.38%)
Gastrointestinal Hemorrhages	5 (.38%)
Gastrointestinal Inflammatory Condi...	5 (.38%)
Protein And Chemistry Analyses	5 (.38%)
Spleen, Lymphatic And Reticulendoth...	5 (.38%)
Angiedema And Urticaria	4 (.31%)
Anxiety Disorders	4 (.31%)
Cardiac And Vascular Disorders Cong...	4 (.31%)
Coagulopathies And Bleeding Diathes...	4 (.31%)
Coronary Artery	4 (.31%)
Fungal Infectious	4 (.31%)
Gastrointestinal Conditions	4 (.31%)
Hypothalamus And Pituitary Gland	4 (.31%)
Immunology And Allergy	4 (.31%)
Neurological, Special Senses And Ps...	4 (.31%)
Obstetric And Gynecological Therape...	4 (.31%)
Peripheral Neuropathies	4 (.31%)
Protein And Amino Acid Metabolism	4 (.31%)
Skin And Subcutaneous Tissue	4 (.31%)
Tissue	4 (.31%)
Bile Duct	3 (.23%)
Depressed Mood Disorders	3 (.23%)
Glucose Metabolism Disorders	3 (.23%)
Inner Ear And Viiith Cranial Nerve	3 (.23%)
Metabolic And Nutritional Disorders...	3 (.23%)
Metabolism	3 (.23%)
Microbiology And Serology	3 (.23%)
Musculoskeletal And Connective Tiss...	3 (.23%)
Peritoneal And Retroperitoneal Cond...	3 (.23%)
Physical Examination Topics	3 (.23%)
Pleural	3 (.23%)
Thyroid Gland	3 (.23%)
Upper Respiratory Tract Disorders	3 (.23%)
Vascular Hypertensive	3 (.23%)
Vascular Inflammations	3 (.23%)
Viral Infectious	3 (.23%)
Administration Site Reactions	2 (.15%)
Appetite And General Nutritional	2 (.15%)
Cardiac Disorder Signs	2 (.15%)
Congenital And Hereditary	2 (.15%)
Cornification And Dystrophic Skin	2 (.15%)
Demyelinating	2 (.15%)
Endocrine Neoplasms Benign	2 (.15%)
Gastrointestinal Stenosis And Obstr...	2 (.15%)
Gastrointestinal Tract Disorders Co...	2 (.15%)
Gastrointestinal Vascular Condition...	2 (.15%)
Hematological And Lymphoid Tissue T...	2 (.15%)
Investigations, Imaging And Histopa...	2 (.15%)
Joint	2 (.15%)
Metabolic, Nutritional And Blood Ga...	2 (.15%)
Mood Disorders	2 (.15%)
Muscle	2 (.15%)
Musculoskeletal And Connective Tiss...	2 (.15%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Di Antalvic, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Di Antalvic is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.